Present On Admission Exempt Codes
ICD-10-CM diagnosis codes exempt from POA reporting based on the official FY2027 CMS POA exempt list.
Advertisements
Codes on this list
38,399 codes, page 273 of 384.
- T45.606DUnderdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter
- T45.606SUnderdosing of unspecified fibrinolysis-affecting drugs, sequela
- T45.611DPoisoning by thrombolytic drug, accidental (unintentional), subsequent encounter
- T45.611SPoisoning by thrombolytic drug, accidental (unintentional), sequela
- T45.612DPoisoning by thrombolytic drug, intentional self-harm, subsequent encounter
- T45.612SPoisoning by thrombolytic drug, intentional self-harm, sequela
- T45.613DPoisoning by thrombolytic drug, assault, subsequent encounter
- T45.613SPoisoning by thrombolytic drug, assault, sequela
- T45.614DPoisoning by thrombolytic drug, undetermined, subsequent encounter
- T45.614SPoisoning by thrombolytic drug, undetermined, sequela
- T45.615DAdverse effect of thrombolytic drugs, subsequent encounter
- T45.615SAdverse effect of thrombolytic drugs, sequela
- T45.616DUnderdosing of thrombolytic drugs, subsequent encounter
- T45.616SUnderdosing of thrombolytic drugs, sequela
- T45.621DPoisoning by hemostatic drug, accidental (unintentional), subsequent encounter
- T45.621SPoisoning by hemostatic drug, accidental (unintentional), sequela
- T45.622DPoisoning by hemostatic drug, intentional self-harm, subsequent encounter
- T45.622SPoisoning by hemostatic drug, intentional self-harm, sequela
- T45.623DPoisoning by hemostatic drug, assault, subsequent encounter
- T45.623SPoisoning by hemostatic drug, assault, sequela
- T45.624DPoisoning by hemostatic drug, undetermined, subsequent encounter
- T45.624SPoisoning by hemostatic drug, undetermined, sequela
- T45.625DAdverse effect of hemostatic drug, subsequent encounter
- T45.625SAdverse effect of hemostatic drug, sequela
- T45.626DUnderdosing of hemostatic drugs, subsequent encounter
- T45.626SUnderdosing of hemostatic drugs, sequela
- T45.691DPoisoning by other fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter
- T45.691SPoisoning by other fibrinolysis-affecting drugs, accidental (unintentional), sequela
- T45.692DPoisoning by other fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter
- T45.692SPoisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela
- T45.693DPoisoning by other fibrinolysis-affecting drugs, assault, subsequent encounter
- T45.693SPoisoning by other fibrinolysis-affecting drugs, assault, sequela
- T45.694DPoisoning by other fibrinolysis-affecting drugs, undetermined, subsequent encounter
- T45.694SPoisoning by other fibrinolysis-affecting drugs, undetermined, sequela
- T45.695DAdverse effect of other fibrinolysis-affecting drugs, subsequent encounter
- T45.695SAdverse effect of other fibrinolysis-affecting drugs, sequela
- T45.696DUnderdosing of other fibrinolysis-affecting drugs, subsequent encounter
- T45.696SUnderdosing of other fibrinolysis-affecting drugs, sequela
- T45.7X1DPoisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), subsequent encounter
- T45.7X1SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela
- T45.7X2DPoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter
- T45.7X2SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela
- T45.7X3DPoisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter
- T45.7X3SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela
- T45.7X4DPoisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter
- T45.7X4SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela
- T45.7X5DAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
- T45.7X5SAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
- T45.7X6DUnderdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter
- T45.7X6SUnderdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela
- T45.8X1DPoisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter
- T45.8X1SPoisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela
- T45.8X2DPoisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter
- T45.8X2SPoisoning by other primarily systemic and hematological agents, intentional self-harm, sequela
- T45.8X3DPoisoning by other primarily systemic and hematological agents, assault, subsequent encounter
- T45.8X3SPoisoning by other primarily systemic and hematological agents, assault, sequela
- T45.8X4DPoisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter
- T45.8X4SPoisoning by other primarily systemic and hematological agents, undetermined, sequela
- T45.8X5DAdverse effect of other primarily systemic and hematological agents, subsequent encounter
- T45.8X5SAdverse effect of other primarily systemic and hematological agents, sequela
- T45.8X6DUnderdosing of other primarily systemic and hematological agents, subsequent encounter
- T45.8X6SUnderdosing of other primarily systemic and hematological agents, sequela
- T45.91XDPoisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter
- T45.91XSPoisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela
- T45.92XDPoisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter
- T45.92XSPoisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela
- T45.93XDPoisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter
- T45.93XSPoisoning by unspecified primarily systemic and hematological agent, assault, sequela
- T45.94XDPoisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter
- T45.94XSPoisoning by unspecified primarily systemic and hematological agent, undetermined, sequela
- T45.95XDAdverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
- T45.95XSAdverse effect of unspecified primarily systemic and hematological agent, sequela
- T45.96XDUnderdosing of unspecified primarily systemic and hematological agent, subsequent encounter
- T45.96XSUnderdosing of unspecified primarily systemic and hematological agent, sequela
- T45.AX1DPoisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), subsequent encounter
- T45.AX1SPoisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), sequela
- T45.AX2DPoisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, subsequent encounter
- T45.AX2SPoisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, sequela
- T45.AX3DPoisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounter
- T45.AX3SPoisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela
- T45.AX4DPoisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, subsequent encounter
- T45.AX4SPoisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, sequela
- T45.AX5DAdverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter
- T45.AX5SAdverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela
- T45.AX6DUnderdosing of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter
- T45.AX6SUnderdosing of immune checkpoint inhibitors and immunostimulant drugs, sequela
- T46.0X1DPoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter
- T46.0X1SPoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela
- T46.0X2DPoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter
- T46.0X2SPoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
- T46.0X3DPoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
- T46.0X3SPoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela
- T46.0X4DPoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
- T46.0X4SPoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela
- T46.0X5DAdverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
- T46.0X5SAdverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
- T46.0X6DUnderdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
- T46.0X6SUnderdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
- T46.1X1DPoisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter
- T46.1X1SPoisoning by calcium-channel blockers, accidental (unintentional), sequela